Coffee + Cardiology

This week the creator of the Seattle Heart Failure Model and Seattle Proportional Risk Model, Dr. Wayne Levy, joins us to discuss how the models were built, the continued evolution of the models, and future of these tools to support clinical decision making with guideline directed therapy.

1:20 - Seattle Heart Failure Model from the beginning
7:30 - Working with Statisticians
8:37 - Making Life Expectancy easier to understand
10:40 - Clinical Applications of the Model
11:35 - Feedback from Clinicians
16:00 - Challenges and successes in building a global model
19:10 - Upkeep and Evolution
22:22 - Barriers to new clinical datesets
23:50 - Future vision of the Model
25:11 - Why not the Levy Model
27:50 - Clinical Insights for risk prediction
33:40 - Defibrillator Paradox
36:15 - Seattle Proportional Risk Model
42:06 - Guideline directed therapy
46:50 - Play with the model
48:44 - Where is the model's future
53:40 - Use across the globe
57:45 - Access the tool and information - See below

Seattle Heart Failure Model
Seattle Proportional Risk Model

Dr, Levy can be reached at [email protected]

Dr. Kenta Nakamura joins us on this week's episode to discuss the history of stem cell research and how he plans to help lead it into the future.   His educational foundation in stem cell biology has intersected with an interventional clinical focus at UW Medicine to now lead a new clinical trial with human vascular endothelial growth factor (VEGF) to induce therapeutic angiogenesis (revascularization).  

Episode topics:
0:38 - Stem Cell Biology and Interventional Cardiology Career
3:55 - Rocky Road of Stem Cell Therapies 
9:25 - Thoughtful process of new clinical trials
10:20 - Techniques and delivery of stem cells
17:50 - Diagnostically measuring success
21:43 - EXACT Clinical Trial - Refractory Angina 
26:20 - Patient Criteria
32:20 - Potential for Young Patients 
37:29 - Motivation for Medicine
39:47 - Advice for Translational Basic Science Careers
43:28 - Outside of work
45:50 - Referrals for Trial

https://clinicaltrials.gov/ct2/show/NCT04125732
@KentaMD
[email protected]

Dr. Shakirar "Lara" Oyetunji, MD, MPH, is a cardiothoracic surgeon with a clinical expertise in the treatment of Hypertrophic Cardiomyopathy at the UW Heart Institute and chief of cardiac surgery at Veterans Administration Puget Sound Health Care System.  

Before all that,  she heard a lot of “Perhaps you should consider something else — nursing, dentistry, nutrition, pharmacy…”  Growing up in Nigeria, she had a role model in her father to believe in her own abilities.  She hopes to inspire that same belief in others through her role in UW's Doctor for a day where she provides underserved K-12 students in the Seattle and Greater Seattle area exposure to medicine and surgery.   In addition to that, her work abroad helping to create of a training program for cardiac surgeons in Nigeria and Rwanda demonstrates a true commitment to nurturing a healthier world, both here and abroad.

Topics:
:18 - From the beginning
4:25 - What would you tell resident you
7:15 - Training and Mentorship Approach
9:47 - Barriers and Bias
16:22 - Addressing Bias
22:20 - Equity vs. Equality
23:41 - Global Health Initiatives
37:45 - Chief of Surgery at the VA
44:47 - The latest in Cardiac Surgery (Hypertrophic Cardiomyopathy)
52:00 - Heart Team Approach

Some links to the topics discussed:
UW's Doctor for a Day Program
TAKE A TEST - Implicit Bias
Implicit Bias in Healthcare Study
Operation Giving Back (OGB) - ACS
Society of Black Academic Surgeon

Dr. Oyetunji's email: [email protected]

Oscar Bailon, MD, FACC, is a board-certified cardiologist that supports the UWMC Northwest and Mill Creek Clinics.  Dr. Bailon believes that best patient care outcomes are achieved incorporating patient preferences, needs and values.   For this episode he brought the instruments he has carried with him since he was in high-school.   He used these instruments to help pay his way through medical school and now to break the ice with his patients.  Additionally, he has played an important role on a regional radio show discussing cardiovascular issues and Covid science for our Spanish speaking population.  His music is magical and you can hear for yourself how he is able to break down barriers.

0:37 - Intro to Peruvian Music and Instruments
2:25 - Beginnings in Peru
4:14 - Song
5:44 - Impact of Song
8:00 - Radio Show
11:06 - Medicine and Music
15:15 - Focus on Purpose
19:30 - Why Cardiology
26:45 - How Radio Improves Healthcare
30:30 - How to connect with different cultures in healthcare
35:00 - Song
35:30 - Integration of song into hospital
37:00 - Instrument descriptions
38:40 - Song
41:40 - Song
43:00 - Learned by ear
46:35 - Song
48:30 - El Rey Radio - SeaMar
53:20 - Song

You can contact Dr. Bailon at [email protected] or by reaching out to us at hipaa.jotform.com/uwheart/referrals

In this episode we host Dr. Stephanie Cooper.   From her start at the center of the AIDS epidemic in San Francisco to how she empowers patients with autonomy in their healthcare decisions at Harborview Medical Center.  This is a must listen for tips on how to navigate those conversations.

1:50 - Becoming Dr. Cooper
4:10 - Beginning of Palliative Care
9:55 - Importance of Communication Skills in Medical Training
11:15 - Trauma informed care
14:55 - Communication Best Practices (Cooper's Touch)
19:45 - Shared Decision Making
21:40 - Patient Autonomy
26:00 - Methamphetamines and the Heart: a historical perspective, update, and considerations of care
37:48 - Investments in Care Needed
46:00 - Trust in Healthcare Team
48:00 - Rocky - Dr. Cooper's Dog

Dr. Cooper is an assistant professor of medicine in the Division of Cardiology.

In addition to practicing general cardiology, she practices palliative medicine within the Department of Medicine at Harborview Medical Center.

She earned her bachelor’s degree at the University of California at Berkeley and earned her M.D. at the University of California at San Francisco.  She completed a medical residency at UCSF and then came to Seattle to complete a fellowship in cardiology and interventional cardiology at University of Washington Medical Center. She was an interventional cardiologist in private practice for 10 years before returning to the UW system to complete a fellowship in palliative medicine.

She is board certified in cardiovascular disease and palliative medicine.

To reach her about her practice and/or research: [email protected]
Dr. Cooper's Grand rounds can be found at the UW Cardiology Youtube Page: Methamphetamines and the Heart: a historical perspective, update, and considerations of care

In this episode we welcome back Dr. Jay Pal our new Surgical Director of MCS and Transplant.

4:00 VAD's past & present 
5:16 Patients & VAD 
7:34 Future VADS 
8:43 Artificial Heart 
12:24 Surgery In's and Out's 
14:35 Best Practices from Experience 
17:00 Why Back to UW? 
18:41 What's in the water at Duke? 
20:10 Regional Partners 
21:20 Partnering with Complexity in Care 
24:16 Future of VADs 
27:20 Thoughts on Allocation Changes 
29:45 Nepal 
37:32 Personal Benefits of Global Health 

Jay Pal, MD, PhD is the Surgical Director of the Heart Transplantation and Mechanical Circulatory Support programs in the Division of Cardiothoracic Surgery. His clinical and research interests lie in the surgical treatment of heart failure, including transplantation and mechanical circulatory support systems.

He completed his general surgical residency at the UCSF Easy Bay program and his thoracic surgery residency at Duke University, where he developed an interest in heart failure. He has held faculty positions at the University of Texas Health Science Center San Antonio and the University of Colorado, as well as at the UW School of Medicine from 2013-2017.

In addition, Dr. Pal has been coordinating an international medical effort in Nepal for several years and will continue this work in collaboration with the Department of Global Health at the University of Washington.

He can be reached any time at [email protected]
or you can use our digital front door: https://hipaa.jotform.com/uwheart/referrals

Thanks for listening!

Coffee and Cardiology with Interventional Cardiologist Dr. Jamie McCabe to talk about what it takes to complete 150 mitraclip procedures, redefining how outcomes are measured, what leadership means to him and his crossroads between furniture making and medicine.

2:57 - Mitraclip
5:30 - Structural Heart Team
7:05 - Dynamics of multidisciplinary teams
9:40 - Volumes (Both sides)
16:40 - TAVR Returns
19:00 - TAVR Patient Selection 
22:10 - Physician Report Cards
25:00 - Risk Treatment Paradox
29:40 - Leadership philosophy 
33:45 - Vision of the Cath lab
37:23 - Impact of Covid
41:06 - Outside of the Lab
42:43 - The furniture maker?
49:08 - The pinnacle of structural heart

Dr. James (Jamie) McCabe grew up in Boston, Massachusetts, graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He has completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology.

Dr. McCabe joined the University of Washington Medical Center in 2013. He became medical director of the Cardiac Cath Labs in 2015 and subsequently was named Chief of Interventional Cardiology for the UW System in 2020. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and valvular heart interventions. Dr. McCabe is an international leader in structural heart interventions including repair or replacement of all heart valves using catheter-based methods. He also treats all forms of coronary artery blockage and cardiogenic shock. He is an internationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease. His research interests focus on quality and performance metrics for cardiovascular procedures and novel transcatheter therapies to address unmet needs in the structural heart space. 

He has been the site principal investigator for dozens of clinical trials and has authored more than 100 original manuscripts and multiple book chapters related to his work. He lectures frequently at national and international meetings including at Transcatheter Cardiovascular Therapeutics (TCT), Trancatheter Valve Therapeutics (TVT), American College of Cardiology (ACC) and Society for Cardiac Angiography and Intervention (SCAI), amongst others. He has also been asked to perform live televised procedures for national and international audiences across multiple continents. 

He has been recognized as an Emerging Leader in Medicine by SCAI and the ACC, named one of three finalists for the Linnemeier Award, and voted a “Top Doc” in cardiology multiple years in a row by Seattle Magazine and Seattle Met Magazine.

To reach Dr. Jamie McCabe you can email him at [email protected].
Or send a referral or consult request here:  https://hipaa.jotform.com/uwheart/referrals

Coffee and Cardiology with Interventional Cardiologist Dr. Bill Lombardi to talk about FAME3, mental health and his passions for patient care. 

Episode Markers:
1:40 TCT Live Cases - Why do them?
3:30 Risk of CTO’s in Live Cases
6:21 Balancing Academics with Procedural Focus
8:50 What Bill learns from Teaching
11:05 Taking a break
13:55 Boundary setting
15:40 How to see the boundaries
16:27 FAME3
25:00 FAME3 Variables in Outcomes
27:21 Training the next generation
31:35 - Get in touch - [email protected] or email [email protected] for his direct contact information.

Dr. Bill Lombardi is a world-renowned expert in Complex Coronary Disease Therapies, performing over 500 interventions a year, including 250 CTOs. 

He continues to develop novel chronic total occlusion (CTO) techniques and technologies, including the inception of a “hybrid algorithm” that facilitates successful, reproducible outcomes in CTO and complex lesion PCI. He has been involved with over 20 new technologies to improve PCI, including guide wires, micro-catheters, specialty balloons and novel approaches to reduce radiation and orthopedic injuries to operators.   

He continues to innovate at the University of Washington Medical Center as clinical professor and Director of the Complex Coronary Disease Therapies Program. 

Dr. Lombardi’s focus remains improving outcomes through numerous collaborations with his colleagues, industry, and teaching the next generation of CTO operators.  

On his free time Dr. Lombardi enjoys spending time with his family on their boat “Lioness”, fishing, and exploring the outdoors.

Find Bill on Twitter @DrBillLombardi

To refer a patient complete this form https://hipaa.jotform.com/uwheart/referrals or reach out to [email protected]